ALLO
Allogene Therapeutics Inc
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $7.71
- Day High
- $7.74
- Day Low
- $7.48
- Day Open
- $7.6
- Volume
- 6175
- Day Change
- 0.58%
Latest news data for ALLO
Allogene Therapeutics Presents Data on Dagger™, a Next Generation AlloCAR T™ Platform Technology
marketscreener.com
Allogene Therapeutics Presents Data on Dagger™, a Next Generation AlloCAR T™ Platform Technology
globenewswire.com
Allogene Therapeutics Publishes Preclinical Data in Clinical Cancer Research Supporting DLL3 as a Potential AlloCAR T™ Target for Small Cell Lung Cancer
globenewswire.com
Allogene stock rises ~15% as JPMorgan upgrades on near-term catalysts
seekingalpha.com
Allogene Therapeutics Announces Publication in Nature Medicine of Data from its Phase 1 UNIVERSAL Study of ALLO-715 for the Treatment of Relapsed/Refractory Multiple Myeloma
globenewswire.com
Yext, 1-800-Flowers.com And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
benzinga.com
Moore Kuehn, PLLC Encourages Investors of Allogene Therapeutics, Inc. to Contact Law Firm
globenewswire.com
Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
marketscreener.com
Global Cell Therapy Market to Surpass US$ 1,391.94 Million by 2030, Says Coherent Market Insights (CMI)
globenewswire.com
Looking Back At The 10 Most Shorted Stocks Of December 2022
forbes.com